David Stokoe
Calico Life Sciences · 259 works · 24,359 citations · h-index 63
Top works
- Activation of Raf as a Result of Recruitment to the Plasma Membrane
- MAPKAP kinase‐2; a novel protein kinase activated by mitogen‐activated protein kinase.
- Dual Role of Phosphatidylinositol-3,4,5-trisphosphate in the Activation of Protein Kinase B
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- Protein Kinase B Kinases That Mediate Phosphatidylinositol 3,4,5-Trisphosphate-Dependent Activation of Protein Kinase B
- Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
- Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
- PDGF stimulates an increase in GTP–Rac via activation of phosphoinositide 3-kinase
- Diverse somatic mutation patterns and pathway alterations in human cancers
- Loss of PTEN facilitates HIF-1-mediated gene expression
- Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins
- Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC
- A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
- Induction of NF-κB by the Akt/PKB kinase
- The substrate specificity and structure of mitogen-activated protein (MAP) kinase-activated protein kinase-2
- Akt activation by growth factors is a multiple-step process: the role of the PH domain
- A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
- High Frequency of Coexistent Mutations of PIK3CA and PTEN Genes in Endometrial Carcinoma
- Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.
- Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to Erlotinib